樂觀
$13.06
情境價格
$6.780
-0.020 (-0.29%)收盤時
United-Guardian, Inc. is a manufacturer of cosmetic ingredients, sexual wellness ingredients, pharmaceuticals, and medical lubricants. The Company’s product lines include the Lubrajel line of multifunctional hydrogel formulations, which are designed to provide sensory enhancement, lubrication, hydration, and texture to both personal care and medical products. Its four distinct product categories include cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. Its COSMOS line of products includes Lubrajel Natural, Lubrajel Marine, Lubrajel Oil Natural, and Lubrajel Terra. Its medical lubricants include a line of hydrogel formulations designed to offer sensory enhancement and lubrication to medical products. The Company’s pharmaceutical products include an FDA-approved prescription drug that is used primarily to prevent and to dissolve calcifications in urethral catheters, as well as a chlorine-based topical antimicrobial.
United-Guardian Inc is currently not a strong buy due to mixed performance indicators. The current price is $6.78, with an RSI of 40.69 indicating a neutral momentum. The forward P/E ratio is 26.53, suggesting that the stock may be overvalued relative to its earnings potential. However, the company has shown a year-to-date change of +10.60%, indicating some resilience. The main risk is the recent revenue decline of 13.5% year-over-year, attributed to market challenges, which could impact future profitability.
情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

United-Guardian Reports Q2 2026 Financial Results

United-Guardian Reports Strong Q1 Growth in Sales and Earnings

Debt-Free Canadian Gold Miners Attracting Investors Amid Market Uncertainty

Upside Gold Updates Kena Project Data, Reveals Larger Mineralized System

United-Guardian Reports Decline in Revenue Amid Market Challenges
United-Guardian, Inc. is a manufacturer of cosmetic ingredients, sexual wellness ingredients, pharmaceuticals, and medical lubricants. The Company’s product lines include the Lubrajel line of multifunctional hydrogel formulations, which are designed to provide sensory enhancement, lubrication, hydration, and texture to both personal care and medical products. Its four distinct product categories include cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. Its COSMOS line of products includes Lubrajel Natural, Lubrajel Marine, Lubrajel Oil Natural, and Lubrajel Terra. Its medical lubricants include a line of hydrogel formulations designed to offer sensory enhancement and lubrication to medical products. The Company’s pharmaceutical products include an FDA-approved prescription drug that is used primarily to prevent and to dissolve calcifications in urethral catheters, as well as a chlorine-based topical antimicrobial. It operates in the Healthcare sector (PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS industry).
United-Guardian Inc is currently not a strong buy due to mixed performance indicators. The current price is $6.78, with an RSI of 40.69 indicating a neutral momentum. The forward P/E ratio is 26.53, suggesting that the stock may be overvalued relative to its earnings potential. However, the company has shown a year-to-date change of +10.60%, indicating some resilience. The main risk is the recent revenue decline of 13.5% year-over-year, attributed to market challenges, which could impact future profitability.
暫無貼文
註冊或登入後參與討論本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。